Evidence map›Paper›PMID 30652094›Full record

ArticleHepatobiliary surgery and nutrition2018

The role of gut microbiota in immune checkpoint inhibitor therapy.

Ming Yi, Shuang Qin, Qian Chu, Kongming Wu

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Hepatobiliary surgery and nutrition, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Immune checkpoint inhibitor associated lichenoid eruptions: a review of non-steroidal systemic maintenance therapies.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Current approaches in glioblastoma multiforme immunotherapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Immune Checkpoint Inhibitors in Cancer Therapy.Current oncology (Toronto, Ont.) · 2022
    Review
  20. Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC.Experimental hematology & oncology · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Ming YiDepartment of Oncology, the Tongji Hospital of Tongji Medical College, the Huazhong University of Science and Technology, Wuhan, 430030, China.
Shuang QinDepartment of Oncology, the Tongji Hospital of Tongji Medical College, the Huazhong University of Science and Technology, Wuhan, 430030, China.
Qian ChuDepartment of Oncology, the Tongji Hospital of Tongji Medical College, the Huazhong University of Science and Technology, Wuhan, 430030, China.
Kongming WuDepartment of Oncology, the Tongji Hospital of Tongji Medical College, the Huazhong University of Science and Technology, Wuhan, 430030, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID30652094
PMCPMC6295392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.